Series A startup

Who invested in Neukio Biotherapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $50MSept 2022
Investors
3
See who backed them

The rounds

  1. Sept 2022

Everyone who backed them

IDG CapitalPrivate equity1round
Lilly Asia VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neukio Biotherapeutics

Who invested in Neukio Biotherapeutics?

Neukio Biotherapeutics's investors include IDG Capital, Lilly Asia Ventures and Sherpa Healthcare Partners.

How much has Neukio Biotherapeutics raised?

Neukio Biotherapeutics has raised $50M across 1 round since 2022.

When did Neukio Biotherapeutics last raise?

Neukio Biotherapeutics's most recent round was a Series A of $50M in Sept 2022.

What was Neukio Biotherapeutics's biggest round?

Its most recent round, $50M in Sept 2022, is also its largest on record.

Who backed Neukio Biotherapeutics first?

Neukio Biotherapeutics's first round on record, in Sept 2022, was backed by IDG Capital, Lilly Asia Ventures and Sherpa Healthcare Partners.

What stage is Neukio Biotherapeutics at?

Neukio Biotherapeutics's latest named round is a Series A, in Sept 2022.

Companies like Neukio Biotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.